Ott Laius
Tartu, Estonia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Introduction of Biopharmaceuticals in Europe: A Cross-Sectional Study of Early Diffusion Patterns and Data Availability.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: June 23, 2025
Prescribing beyond borders: Navigating challenges and opportunities in cross-border ePrescriptions for enhanced medication access and safety.
Journal: Research in social & administrative pharmacy : RSAP
Published: March 01, 2024
Compliance with Pregnancy Prevention Recommendations for Isotretinoin Following the Amendment of the European Union Pregnancy Prevention Program: A Repeat Study in Estonia.
Journal: Drugs - real world outcomes
Published: June 27, 2023
Outpatient fluoroquinolone use in relation to European Medicines Agency's recommendation: An Estonian nationwide drug utilization study.
Journal: Pharmacoepidemiology and drug safety
Published: September 09, 2022
Implementation of European Cross-border Electronic Prescription and Electronic Dispensing Service: Cross-sectional Survey.
Journal: Journal of medical Internet research
Published: September 05, 2022
Corrigendum to "Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications".
Journal: BioMed research international
Published: August 08, 2022
Pre-pregnancy counseling for women with epilepsy: Can we do better?
Journal: Epilepsy & behavior : E&B
Published: September 23, 2021
Trends in the use of hormonal contraception in Estonia 2005-2019 and the risk of arterial and venous thromboembolism: a population-based study.
Journal: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
Published: June 23, 2021
Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications.
Journal: BioMed research international
Published: March 26, 2021
The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future.
Journal: Frontiers in public health
Published: February 24, 2021
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: February 04, 2021
The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures.
Journal: Frontiers in pharmacology
Published: August 03, 2020
Last Updated: 09/26/2026